Respiratory illnesses like RSV, COVID-19, flu, and the common cold spike annually. Johns Hopkins experts debunk myths and ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is ...

U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a "quad-demic." Here what you can do.

Most people recover in a week or two, but RSV can become serious for babies, adults over the age of 65 and those with impaired immune systems. Steve Threlkeld, a doctor and director of infectious ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

Alone and in combination with other lower respiratory tract disease signs and symptoms, dyspnea is the best predictor of severe RSV outcomes.

Additionally, just 44.5% of adults ages 75 and older have received the RSV vaccine, according to CDC data. Nearly half of all children are vaccinated against the flu at 42.9%, but just 11% have ...